[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366597-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-366597-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","upp1-and-ahsa1-as-emerging-biomarkers-and-targets-in-pancreatic-cancer-a-proteomic-approach","UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer - A proteomic approach","","Pancreatic cancer pathogenesis and differentiation-dependent molecular targets remain incompletely characterized. Proteomic profiling of pancreatic tumor tissues across differentiation grades, together with adjacent para-cancer tissues, identified differentially expressed proteins (DEPs) using bioinformatics and pathway analyses. Key candidates were validated by GEPIA, RT-qPCR, Western blotting, immunohistochemistry, and immunofluorescence. Overall, 431 DEPs differentiated cancer from para-PC tissues, and 470 DEPs distinguished poorly differentiated from moderately differentiated cancers. Five DEPs were common across comparisons, with UPP1 and AHSA1 showing the most pronounced expression increases, especially in poorly differentiated tumors. Results consistently supported their roles as differentiation- and progression-associated proteins with diagnostic and therapeutic potential, motivating precision-treatment strategies.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/upp1-and-ahsa1-as-emerging-biomarkers-and-targets-in-pancreatic-cancer-a-proteomic-approach/366597/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/upp1-and-ahsa1-as-emerging-biomarkers-and-targets-in-pancreatic-cancer-a-proteomic-approach/366597.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study in pancreatic cancer research?","Question",{"text":63,"@type":64},"The study aims to identify molecular differences between poorly differentiated and moderately differentiated pancreatic cancers and to discover key regulatory proteins and pathways linked to differentiation and progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which protein targets are highlighted as emerging biomarkers and therapeutic candidates?",{"text":68,"@type":64},"Uridine Phosphorylase 1 (UPP1) and Activator of HSP90 ATPase Activity 1 (AHSA1) are emphasized as showing particularly notable differential expression and consistent validation across multiple assays.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the candidate biomarkers validated in this research?",{"text":72,"@type":64},"Validation used GEPIA database analysis plus experimental approaches including RT-qPCR, Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF).",{"name":74,"@type":61,"acceptedAnswer":75},"What differentiation-related pattern did UPP1 and AHSA1 show?",{"text":76,"@type":64},"UPP1 and AHSA1 were significantly upregulated in pancreatic cancer tissues versus adjacent non-cancerous tissues, and their expression was even higher in poorly differentiated cancers compared with moderately differentiated ones.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},366597,1790196186,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","RESEARCH ARTICLE  \nUPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer: A proteomic approach  \nKongfan Zhu 1\\#, Hua Hu 2\\#, Yuanfa Tao 1, Zhijian Yang 1, and Hanjun Li 1 ∗  \nThe specific protein targets involved in pancreatic cancer (PC) pathogenesis and its varying levels of differentiation remain incompletely understood. Advanced proteomic methodologies provide a powerful means of identifying key regulatory proteins and signaling pathways central to cancer progression. In this study, proteomic analyses were performed on PC tissue samples of different differentiation grades, along with adjacent non-cancerous (para-PC) tissues. Bioinformatics techniques were used to identify differentially expressed proteins (DEPs) and their associated pathways. Key target proteins were validated using the Gene Expression Profiling Interactive Analysis (GEPIA) database, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). A total of 431 DEPs were identified between PC and para-PC tissues, while 470 DEPs distinguished poorly differentiated (PD) from moderately differentiated (MD) PCs. Functional enrichment analysis revealed that these DEPs participate in various biological processes and signaling pathways. Five DEPs were common to both comparisons, with Uridine Phosphorylase 1 (UPP1), Lactamase Beta, and Activator of HSP90 ATPase Activity 1 (AHSA1) showing particularly notable differences. UPP1 and AHSA1 were significantly upregulated in PC tissues relative to adjacent tissues and exhibited even higher expression in PD-PCs compared to MD ones. These findings were consistently supported by GEPIA, RT-qPCR, Western blotting, IHC, and IF analyses. This study identifies UPP1 and AHSA1 as key proteins linked to PC differentiation and progression, highlighting their potential as diagnostic markers and therapeutic targets. These insights enhance our understanding of the molecular mechanisms underlying PC and open new avenues for precision treatment strategies.  \nKeywords: Pancreatic cancer, PC, proteomics, differentiated pancreatic cancer, target, experimental validation.  \nIntroduction  \nPancreatic cancer (PC) is an aggressive and deadly malignancy, projected to become the second leading cause of cancer-related deaths by 2030 [1] . Despite advances in detection and treatment, the ﬁve-year survival rate remains below 10%, placing PC among the cancers with the poorest prognosis [2] . PC ishistologically classiﬁed aswell-diﬀerentiated (WD), moderately diﬀerentiated (MD), or poorly diﬀerentiated (PD), with PD-PC exhibiting the greatest invasiveness and worst outcomes [3] . Globally, the incidence of PC continues to rise [4] . Major risk factors include tobacco use, obesity, impaired glucose metabolism, and chronic pancreatitis [5] . At the molecular level, KRAS mutations—present in about 90% of patients—area key driver of PC [6], along with common alterations in TP53, CDKN2A, and SMAD4 [7] . Although these mutations may diﬀer by tumor grade, the relationship between genetic alterationsand PC diﬀerentiation remains poorly understood. Early detection of PC remains a major challenge. Currently, dual-phase contrast-enhanced CT is the gold standard for imaging, while MRI may be beneﬁcial for high-risk populations [8] . However, the development of more sensitive and speciﬁc biomarkers for  \nearly diagnosis remains an urgent unmet need [9]. Proteomics, a rapidly advancing ﬁeld, provides powerful tools for exploring cancer biology and identifying novel therapeutic targets. Recent studies underscore the potential of proteomics in oncology. For instance, Yang et al. [10] identiﬁed KDM1A as a therapeutic target in early-stage esophageal squamous cell carcinoma (ESCC) using a multi-omics approach. Nam et al. [11] found that 2-aminoethanethiol dioxygenase (ADO) may serve as a prognostic marker and therapeutic target in PC. Similarly, Feng et al. [12] used p","cbCain3ghBKp5jnp","https://ap.wps.com/l/cbCain3ghBKp5jnp","pdf",5513057,15,"English","# Keywords\n# Introduction\n## Pancreatic cancer burden and risk factors\n## Molecular drivers and grade-dependent behavior\n## Diagnostic challenges and biomarker need\n## Proteomics in oncology and prior studies\n# Results and validation (overview)\n## Differentially expressed proteins across comparisons\n## Shared candidates and UPP1/AHSA1 expression pattern\n## Experimental confirmation methods\n# Conclusion and implications","[{\"question\":\"What is the main goal of this study in pancreatic cancer research?\",\"answer\":\"The study aims to identify molecular differences between poorly differentiated and moderately differentiated pancreatic cancers and to discover key regulatory proteins and pathways linked to differentiation and progression.\"},{\"question\":\"Which protein targets are highlighted as emerging biomarkers and therapeutic candidates?\",\"answer\":\"Uridine Phosphorylase 1 (UPP1) and Activator of HSP90 ATPase Activity 1 (AHSA1) are emphasized as showing particularly notable differential expression and consistent validation across multiple assays.\"},{\"question\":\"How were the candidate biomarkers validated in this research?\",\"answer\":\"Validation used GEPIA database analysis plus experimental approaches including RT-qPCR, Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF).\"},{\"question\":\"What differentiation-related pattern did UPP1 and AHSA1 show?\",\"answer\":\"UPP1 and AHSA1 were significantly upregulated in pancreatic cancer tissues versus adjacent non-cancerous tissues, and their expression was even higher in poorly differentiated cancers compared with moderately differentiated ones.\"}]","UPP1 and AHSA1 as emerging biomarkers and targets in pancreatic cancer - A proteomic approach | PDF",1790166343,38,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6dc7443b9a8fdf23ea971f4821674db.webp",983,1272,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac086cd1b8155aa91907e6a2b199345d.webp",982,1270,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/777e7fafd77b15d85bb376ec6fd33b00.webp",981,1269,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33901f743ad66628c20428d9b7f57374.webp",980,1268]